BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26282458)

  • 41. A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia.
    Zhang K; Chen X; Li H; Feng G; Nie Y; Wei Y; Li N; Han Z; Han ZC; Kong D; Guo Z; Zhao Q; Li Z
    Acta Biomater; 2020 Sep; 113():289-304. PubMed ID: 32663662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alginate-Encapsulated Mesenchymal Stromal Cells Improve Hind Limb Ischemia in a Translational Swine Model.
    Deppen JN; Ginn SC; Tang EO; Wang L; Brockman ML; Levit RD
    J Am Heart Assoc; 2024 May; 13(9):e029880. PubMed ID: 38639336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemia.
    Harada Y; Yamamoto Y; Tsujimoto S; Matsugami H; Yoshida A; Hisatome I
    Biomed Res; 2013 Feb; 34(1):23-9. PubMed ID: 23428977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transplantation of erythropoietin gene-transfected umbilical cord mesenchymal stem cells as a treatment for limb ischemia in rats.
    Li JP; Wang DW; Song QH
    Genet Mol Res; 2015 Dec; 14(4):19005-15. PubMed ID: 26782551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
    Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
    Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced angiogenesis in ischemic skeletal muscle after transplantation of cell sheets from baculovirus-transduced adipose-derived stromal cells expressing VEGF165.
    Makarevich PI; Boldyreva MA; Gluhanyuk EV; Efimenko AY; Dergilev KV; Shevchenko EK; Sharonov GV; Gallinger JO; Rodina PA; Sarkisyan SS; Hu YC; Parfyonova YV
    Stem Cell Res Ther; 2015 Oct; 6():204. PubMed ID: 26503601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-dimensional cell aggregates composed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia.
    Chen DY; Wei HJ; Lin KJ; Huang CC; Wang CC; Wu CT; Chao KT; Chen KJ; Chang Y; Sung HW
    Biomaterials; 2013 Mar; 34(8):1995-2004. PubMed ID: 23245925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model.
    Zhao Y; Gillen JR; Harris DA; Kron IL; Murphy MP; Lau CL
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1668-1677.e5. PubMed ID: 24199758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia.
    Ishii M; Numaguchi Y; Okumura K; Kubota R; Ma X; Murakami R; Naruse K; Murohara T
    Atherosclerosis; 2009 Sep; 206(1):109-18. PubMed ID: 19344900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancing Therapeutic Efficacy and Reducing Cell Dosage in Stem Cell Transplantation Therapy for Ischemic Limb Diseases by Modifying the Cell Injection Site.
    Shin JY; Yoon JK; Noh MK; Bhang SH; Kim BS
    Tissue Eng Part A; 2016 Feb; 22(3-4):349-62. PubMed ID: 26824782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.
    Zhang Y; Zhang R; Li Y; He G; Zhang D; Zhang F
    Mol Biol Rep; 2012 Jan; 39(1):285-93. PubMed ID: 21553056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.
    Zhu H; Sun A; Zhu H; Li Z; Huang Z; Zhang S; Ma X; Zou Y; Hu K; Ge J
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):894-901. PubMed ID: 24558108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis.
    Kwon HM; Hur SM; Park KY; Kim CK; Kim YM; Kim HS; Shin HC; Won MH; Ha KS; Kwon YG; Lee DH; Kim YM
    Vascul Pharmacol; 2014 Oct; 63(1):19-28. PubMed ID: 24998908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiogenic properties of mesenchymal stem cells in a mouse model of limb ischemia.
    Martins L; Martin PK; Han SW
    Methods Mol Biol; 2014; 1213():147-69. PubMed ID: 25173381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
    Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
    J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cellular delivery system fabricated with autologous BMSCs and collagen scaffold enhances angiogenesis and perfusion in ischemic hind limb.
    Wang J; Cui W; Ye J; Ji S; Zhao X; Zhan L; Feng J; Zhang Z; Zhao Y
    J Biomed Mater Res A; 2012 Jun; 100(6):1438-47. PubMed ID: 22378701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells.
    Nishishita T; Ouchi K; Zhang X; Inoue M; Inazawa T; Yoshiura K; Kuwabara K; Nakaoka T; Watanabe N; Igura K; Takahashi TA; Yamashita N
    Biochem Biophys Res Commun; 2004 Dec; 325(1):24-31. PubMed ID: 15522196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
    Zhao N; Yue Z; Cui J; Yao Y; Song X; Cui B; Qi X; Han Z; Han ZC; Guo Z; He ZX; Li Z
    Stem Cell Res Ther; 2019 Apr; 10(1):129. PubMed ID: 31036073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model.
    Long J; Wang S; Zhang Y; Liu X; Zhang H; Wang S
    J Vasc Surg; 2013 Sep; 58(3):756-65.e2. PubMed ID: 23562340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human placenta-derived multipotent mesenchymal stromal cells involved in placental angiogenesis via the PDGF-BB and STAT3 pathways.
    Chen CY; Liu SH; Chen CY; Chen PC; Chen CP
    Biol Reprod; 2015 Oct; 93(4):103. PubMed ID: 26353894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.